Home
Grupos
Páginas
Más
Grupos Páginas Eventos Blogs Ofertas Empleos Courses Foros Películas Juegos
Iniciar sesión Registrarse
Day Mode
Antisense Oligonucleotide for Cardiometabolic Disorders Market Advances with Expanding Precision Medicine Research and Innovative RNA-Based Therapeutic Development
According to the latest report published by Data Bridge Market Research, the Antisense Oligonucleotide for Cardiometabolic Disorders Market The global antisense oligonucleotide for cardiometabolic disorders market size was valued at USD 310.32 million in 2024 and is expected to reach USD 1,135.19 million by 2032, at a CAGR of 17.60% during the forecast period With the use of...
0 Commentarios ·0 Acciones ·65 Views ·0 Vista previa
Please log in to like, share and comment!
Upgrade to Pro
Choose the Plan That's Right for You
Upgrade